Newsletter

This stock has gained 60% or more every time it's been alerted. That's why it's a cash cow.
This stock is the closest you'll get to a sure thing.
It seems like every few weeks this stock's share price consolidates and inches its way back to 5 cents. That's great for us because every time it has the magic follows not far behind.
That's why this trade opportunity is key. Exploring new sectors and identifying undervalued stocks is always fun, but identifying a stock which pumps out profits like clockwork is even better.
That's why I call this stock a cash cow. Every time I have alerted it my readers have had opportunities to score 60% in profits or more. Back in February this stock even produced a massive rally where share prices surged from .03 to .10 producing gains of over 200%.
Well, it's time yet again to take advantage of the opportunity before you. There's no such thing as a sure thing in the stock market. There never has been.
However, this stock is the closest you'll ever get to such a "unicorn".
Currently, the situation is almost identical to the last time I alerted this stock. Share prices were around .055 and the stock opened at the low of the day and hit .09 as the day went on. This represents a gain of over 60% in single day.
That's what we are most likely in for yet again.
Remember, with opportunities like this the first to act is often times the biggest winner.
That's why you have to prepare right now. Traders have to make sure they are in a position to trade right at the opening bell (9:30AM EST) on Friday. If you wait around thinking you could find a better entry price then you could be forfeiting on a substantial amount of profits and regret it later on.
However, there's no reason to have any regret since I'm giving you a head start. You have an opportunity to trade knowing that everyone else will be late to the party if they haven't pulled the trigger early Friday morning.
This is your time to profit. Beat everyone else to the punch.

SNDY Is About To Price In Its Latest Breaking Development

Good Morning!

Solos Endoscopy, Inc. (OTCPINK: SNDY)
A very bullish chart setup and a very breaking news development have created the prefect storm for you to capitalize on SNDY.
You might remember this play because I have alerted it in the past. In fact, it’s one of the most consistent winners I have delivered and I expect this time round to be no less lucrative.
Over the last few sessions a set of key technical factors have positioned SNDY for a potentially huge rally. First, SNDY is trading well below its 13-week high of .15. Based on my calculations at the time of writing, traders have around 200% upside opportunity on the table. SNDY is also trading below its 4-week high of .13 – the upside opportunity there is around 160%.
The second technical factor that is powering the bullish confidence in a SNDY breakout is its daily volatility. This has been rising in recent session and its most recent session saw a volume breakout of more than 53%.
You should also know that even after the wave of profit taking, SNDY is still holding a “buy” rating at Barchart.com. This fact shouldn’t be overlooked because it shows in no small way that SNDY has the requisite amount of upside potential to retain such a bullish rating.
The technicals alone are more than capable of making SNDY pop but the ace up your sleeve is the strong news just released by the company. SNDY has just resumed sales of its MammoView® Ductoscopy Instruments. This is extremely fresh news!
Get ready to move on SNDY right now because the combination of factors outlined is bound to make it pop.
Check out the chart…

Here’s a link to the chart: http://www.barchart.com/interactive_charts/stocks/SNDY

About 
SNDY (Solos Endoscopy, Inc.) is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office.
US Medical Device Set To Reach $133 Billion By The End Of 2016
The United States remains the largest medical device market in the world with a market size of around $110 billion, and it is expected to reach $133 billion by 2016.  The U.S. market value represented about 38 percent of the global medical device market in 2012.  U.S. exports of medical devices in key product categories identified by the Department of Commerce (DOC) exceeded $44 billion in 2012, a more than 7 percent increase from the previous year.
There are more than 6,500 medical device companies in the U.S., mostly small and medium-sized enterprises (SMEs).  More than 80 percent of medical device companies have fewer than 50 employees, and many (notably innovative start-up companies) have little or no sales revenue.  Medical device companies are located throughout the country, but are mainly concentrated in regions known for other high-technology industries, such as microelectronics and biotechnology.  The states with the highest number of medical device companies include California, Florida, New York, Pennsylvania, Michigan, Massachusetts, Illinois, Minnesota and Georgia.  Other states with significant sector employment include Washington, Wisconsin, and Texas.
News Development 
Solos Endoscopy Fulfills Backorders for MammoView(R) Ductoscopy Instruments
SNDY has just announced that it has resumed sales of its MammoView® Ductoscopy Instruments as a result of its ability to fulfil all of its backorders, which were due to production issues experienced from one of its component manufacturers. The component manufacturer has resolved its production issue and has resumed its deliveries, on a timely basis, to Solos and is confident that it will not experience this issue in the future.
"The production issues have been successfully addressed and I'm confident in the uninterrupted sale and production of the MammoView® product line going forward," stated Robert Segersten, CEO.
Mammary ductoscopy is designed to provide physicians the means to detect, diagnose, and treat breast cancer years before surgery, physical exams or other external imaging, which can reveal evidence of the disease. The Solos Breast Endoscopy System employs advanced microendoscopes and optical technology to give physicians sharp, clear images of the milk ducts, where the majority of the breast cancers arise. Solos' intraductal devices are designed to provide direct observation with any endoscopic video system while providing unprecedented image quality, using advanced minimally invasive technologies and tissue preservation techniques.
To learn more about SNDY please visit their website: http://www.solosendoscopy.com/
The bullish chart and the extremely fresh and important news are reasons enough for you to move on SNDY right now. Don’t miss out.

BEATPENNYSTOCKS

DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by Stellar Media Group, LLC.  Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” or “Stellar Media” refers to Stellar Media Group, LLC.  Our business model is to be financially compensated to market and promote small public companies.  By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.

We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. Stellar Media’s business model is to receive financial compensation to promote public companies.  We have been compensated $15k cash via bank wire by a third party, ACN, LLC, to conduct investor relations advertising and marketing for SNDY. This compensation is a major conflict of interest in our ability to be unbiased regarding . Therefore, this communication should be viewed as a commercial advertisement only.  We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices.  Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forword looking statements, which are not guaranteed to materialize due to a variety of factors.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Stellar Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at http://www.beatpennystocks.com/disclaimer/.

BEATPENNYSTOCKS

DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by Stellar Media Group, LLC.  Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” or “Stellar Media” refers to Stellar Media Group, LLC.  Our business model is to be financially compensated to market and promote small public companies.  By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.

 We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. Stellar Media’s business model is to receive financial compensation to promote public companies.  We have been compensated $15k cash via bank wire by a third party, ACN, LLC, to conduct investor relations advertising and marketing for SNDY. This compensation is a major conflict of interest in our ability to be unbiased regarding . Therefore, this communication should be viewed as a commercial advertisement only.  We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices.  Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forword looking statements, which are not guaranteed to materialize due to a variety of factors.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Stellar Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at http://www.beatpennystocks.com/disclaimer/.

This message was sent to xxxxxx@gmail.com from:
BeatPennyStocks | info@beatpennystocks.com | DamnGoodPennyPicks | 1357 Broadway | New York, NY 10018

Email Marketing by  

 Unsubscribe 

Stocks covered:	Compensation:	Avg $ Volume for Period:
SNDY	$15000	UNKNOWN
Max Profit: 4.48 %	Gain at close: 0.00 %
*We think that this promoter is a part of a group of promoters.

Newsletter

This stock is practically a unicorn. Profits inside. Mar 17, 2016 20:35